Literature DB >> 24377511

Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer.

Jing Bian1, Bo Li, Xian-Juan Kou, Tian-Zhou Liu, Liang Ming.   

Abstract

OBJECTIVE: To explore the predictive value of tumor markers, including cancer antigen 72-4 (CA72-4), cancer antigen 15-3 (CA15-3) and cancer antigen 125 (CA125), in single or combined detection, for the diagnosis of ovarian cancer.
METHODS: 120 patients diagnosed with ovarian cancer from August 2011 to March 2013 and 80 patients diagnosed with benign ovarian tumors were enrolled in this test, along with 50 health examination women randomly selected from the database as controls. Serum levels of CA72-4, CA15-3 and CA125 in this study were determined by electrochemiluminescence (ECL).
RESULTS: Serum levels of CA72-4, CA15-3 and CA125 in ovarian cancer were higher than those in healthy group and benign group (P<0.01).The sensitivity of combined detection of those three tumor markers for diagnosis of ovarian cancer was obviously higher than with single detection with each marker (P<0.01).
CONCLUSIONS: CA72-4, CA15-3 and CA125 could be a good combination in the diagnosis of ovarian cancer. Patients whose tumor markers continue to increase should be highly suspected of malignancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24377511     DOI: 10.7314/apjcp.2013.14.11.6241

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Changing trends in the incidence of ovarian neoplasia and its relationship with the risk factors: a report of 311 cases from north-eastern anatolia region.

Authors:  Elif Demirci; Ferah Tuncel Daloglu; Muhammet Calik; Eren Altun; Sare Sipal; Bunyamin Borekci
Journal:  Eurasian J Med       Date:  2014-08-26

2.  Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.

Authors:  Song Zhao; Yu Mei; Yongmei Wang; Jiang Zhu; Guixi Zheng; Rong Ma
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer.

Authors:  Hao Lai; Qinwen Jin; Yuan Lin; Xianwei Mo; Bo Li; Ke He; Jiansi Chen
Journal:  Tumour Biol       Date:  2014-07-25

4.  Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancer.

Authors:  Paul Buderath; Sabine Kasimir-Bauer; Bahriye Aktas; Jens Rasch; Rainer Kimmig; Thomas Zeller; Martin Heubner
Journal:  Future Sci OA       Date:  2016-10-12

5.  Complete response to orally administered melphalan in malignant pleural effusion from an occult female genital organ primary neoplasm with BRCA1/2 mutations: a case report.

Authors:  Frank S Fan; Chung-Fan Yang
Journal:  J Med Case Rep       Date:  2018-05-06

6.  Detection of ovarian cancer (± neo-adjuvant chemotherapy effects) via ATR-FTIR spectroscopy: comparative analysis of blood and urine biofluids in a large patient cohort.

Authors:  Panagiotis Giamougiannis; Camilo L M Morais; Brice Rodriguez; Nicholas J Wood; Pierre L Martin-Hirsch; Francis L Martin
Journal:  Anal Bioanal Chem       Date:  2021-07-01       Impact factor: 4.142

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.